Cardiac Diagnostics

This channel includes news, videos, podcasts and other content on new technology innovations for cardiac diagnostic systems and techniques. This includes laboratory testing, blood tests including troponin testing, electrocardiogram (ECG) systems, point of care testing systems, genetic testing, cardiac patient monitoring devices including wearable sensors, and studies showing new ways to diagnose heart diseases.

Cleerly has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging
News | Artificial Intelligence
Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

February 13, 2024 — Cleerly, a digital healthcare company focused on artificial intelligence (AI)-driven heart disease ...

Home February 13, 2024
Home
ResearcherLate-breaking science from the American Stroke Association’s International Stroke Conference, ISC 2024, reports researchers found an artificial intelligence (AI) system to help guide treatment decisions for stroke patients led to improved stroke care quality and fewer recurrent strokes, heart attacks and vascular death among stroke survivors three months after a stroke.
News | AHA
International Stroke Conference Researcher Finds AI-based System Helped Guide Treatment, Lowered Stroke Recurrence

February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s Internation ...

Home February 08, 2024
Home
The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is deemed appropriate by a heart team.
News | FDA
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy Earns FDA Approval for Tricuspid Valve

February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is ...

Home February 02, 2024
Home
The companies will jointly support a series of educational forums among clinicians beginning later this year highlighting the significant new scientific breakthroughs that are radically transforming the traditional approach to heart disease prevention and prediction
News | Pharmaceuticals
Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to this guest column author who addresses the importance of identifying and reducing residual inflammatory risk.
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil
Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
A public-private partnership Think Tank
News | Cardiovascular Education
Cardiac Safety Research Consortium Announces Think Tank Program with FDA Regulators, Industry and Academia Focused on Cardiac Remote Monitoring Trials and AI

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the Card ...

Home January 15, 2024
Home
Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with Pfizer to support the validation and FDA clearance of its AI-based technology for the detection of cardiac amyloidosis.
News | Artificial Intelligence
Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

January 15, 2024 — Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the ...

Home January 15, 2024
Home
New research from Mayo Clinic suggests that AI could improve the diagnosis of peripartum cardiomyopathy
News | Artificial Intelligence
Clinical Research Shows AI-enabled Digital Stethoscope can Detect Pregnancy-related Heart Disease

January 9, 2024 — New research from Mayo Clinic suggests that artificial intelligence (AI) could improve the diagnosis ...

Home January 09, 2024
Home
CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally
News | Wearables
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio monitor and ZEUS System

January 3, 2024 — iRhythm Technologies, Inc., a leading digital health care company focused on creating trusted ...

Home January 03, 2024
Home
This patient milestone and the recent launch of Plaque Analysis and RoadMap Analysis further solidify HeartFlow as a pioneer in AI-enabled CAD diagnostics
News | FFR Technologies
HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis

January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care ...

Home January 03, 2024
Home
Results from an ongoing clinical study conducted by Scripps Clinic indicate that MindMics' non-invasive IH technology can detect aortic stenosis by capturing in-ear acoustic vibrations throughout the cardiac cycles
News | Patient Monitors
MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new ...

Home December 26, 2023
Home
Company appoints Mohammad Shokoohi-Yekta to lead program and industry pioneer Lance Myers as advisor
News | Artificial Intelligence
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

December 22, 2023 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power ...

Home December 22, 2023
Home
ECGI vest developed at UCL being worn by a UCL medical student
News | Sudden Cardiac Arrest
Heart Vest Could Help Predict Sudden Cardiac Death Risk

December 19, 2023 — A vest that can map the electrical activity of the heart in fine detail could potentially be used to ...

Home December 19, 2023
Home
News | Cardiovascular Clinical Studies
Clinical Trial Results from Peerbridge Health Unveil Direct-from-ECG Sleep Apnea Detection Using COR Wearable Platform

December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective ...

Home December 19, 2023
Home
Early detection of atrial fibrillation can reduce the risk of stroke and heart failure, but screening people for the condition has been historically challenging
News | Atrial Fibrillation
New AI-powered Algorithm Could Better Assess People’s Risk of Common Heart Condition

December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help ...

Home December 13, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now